Similar articles

• Central nervous system depressants. II. 4-Allyloxy-3,5-dialkylbenzoic acids and derivatives.

  MOFFETT RB, SEAY PH. MOFFETT RB, et al. J Med Pharm Chem. 1960 Apr;2:201-12. doi: 10.1021/jm50009a007. J Med Pharm Chem. 1960. PMID: 14423226 No abstract available.
• Central nervous system depressants. III. 2- and 4-Allyloxy-3,5-disubstituted benzoic acids and derivatives.

  MOFFETT RB, SEAY PH. MOFFETT RB, et al. J Med Pharm Chem. 1960 Apr;2:213-27. doi: 10.1021/jm50009a008. J Med Pharm Chem. 1960. PMID: 14423227 No abstract available.
• Pharmacology of a series of nuclear substituted phenyltertiary-butylamines with particular reference to anorexigenic and central stimulating properties.

  HOLM T, HUUS I, KOPF R, MOLLER NIELSEN I, PETERSEN PV. HOLM T, et al. Acta Pharmacol Toxicol (Copenh). 1960;17:121-36. doi: 10.1111/j.1600-0773.1960.tb01236.x. Acta Pharmacol Toxicol (Copenh). 1960. PMID: 13715432 No abstract available.
• SYNERGISM. WITH SPECIAL REFERENCE TO CENTRAL NERVOUS SYSTEM DEPRESSANTS.

  ROSSI GV. ROSSI GV. J Pharm Sci. 1963 Sep;52:819-32. doi: 10.1002/jps.2600520903. J Pharm Sci. 1963. PMID: 14061039 Review. No abstract available.
• Pharmacology of the central nervous system.

  Shellenberger MK, Walaszek EJ. Shellenberger MK, et al. Prog Neurol Psychiatry. 1972;27:67-86. Prog Neurol Psychiatry. 1972. PMID: 4145416 Review. No abstract available.